A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and Dexamethasone

<div>Left paravertebral plasmacytoma biopsy on (a) haematoxylin and eosin (H&amp;E) stain, (b) immunohistochemical (IHC) stain of kappa and lambda light chain, (c) IHC stain of p53, (d) FISH of IGH breakapart, and (e) FISH of TP53 deletion.</div>

Case Reports in Hematology

fig1

Figure 1

Figure 1: A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and Dexamethasone 

Figure 1 | A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and Dexamethasone 